Straumann (STMN.SW)

Executive Summary

Straumann is a global leader in dental implantology and restorative dentistry, headquartered in Basel, Switzerland. The company offers a comprehensive portfolio of dental implants, prosthetics, digital solutions, biomaterials, and clear aligners, supported by extensive training and evidence-based protocols. Straumann's strong brand, robust R&D, and focus on digital dentistry have driven consistent market share gains. The aging population, rising disposable incomes, and increasing awareness of oral health underpin long-term demand. Despite macroeconomic headwinds, Straumann's exposure to high-growth segments like clear aligners and digital workflows positions it for sustained mid-single-digit revenue growth and margin expansion. The company's diversified geographic footprint and recurring revenue from consumables provide resilience. Near-term tailwinds include easing supply chains and normalizing dental visit volumes. Straumann remains a high-quality compounder with a strong competitive moat.

Upcoming Catalysts (preview)

• Q3 2026Q2 2026 Earnings Release90% success
• H2 2026Launch of Next-Generation Digital Platform or Implant System70% success
• 2026Strategic Acquisition or Partnership in Clear Aligners or Biomaterials60% success